Case and Research Letter
Neuroendocrine TumorWith an Atypical Clinical Course: A Description of 2 Cases
Tumor neuroendocrino: descripción de 2 casos de evolución atípica
Leído
7221
Vecesse ha leído el artículo
2188
Total PDF
5033
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 115 | 9 | 124 |
| 2025 5 | 172 | 38 | 210 |
| 2025 4 | 145 | 20 | 165 |
| 2025 3 | 140 | 13 | 153 |
| 2025 2 | 147 | 28 | 175 |
| 2025 1 | 102 | 22 | 124 |
| 2024 12 | 108 | 33 | 141 |
| 2024 11 | 118 | 73 | 191 |
| 2024 10 | 83 | 41 | 124 |
| 2024 9 | 88 | 27 | 115 |
| 2024 8 | 114 | 50 | 164 |
| 2024 7 | 85 | 32 | 117 |
| 2024 6 | 114 | 27 | 141 |
| 2024 5 | 89 | 23 | 112 |
| 2024 4 | 89 | 25 | 114 |
| 2024 3 | 77 | 35 | 112 |
| 2024 2 | 91 | 25 | 116 |
| 2024 1 | 59 | 38 | 97 |
| 2023 12 | 79 | 14 | 93 |
| 2023 11 | 86 | 33 | 119 |
| 2023 10 | 85 | 29 | 114 |
| 2023 9 | 88 | 29 | 117 |
| 2023 8 | 53 | 21 | 74 |
| 2023 7 | 56 | 32 | 88 |
| 2023 6 | 56 | 25 | 81 |
| 2023 5 | 52 | 28 | 80 |
| 2023 4 | 45 | 15 | 60 |
| 2023 3 | 39 | 13 | 52 |
| 2023 2 | 50 | 24 | 74 |
| 2022 1 | 33 | 19 | 52 |
| 2022 12 | 52 | 44 | 96 |
| 2022 11 | 24 | 33 | 57 |
| 2022 10 | 29 | 21 | 50 |
| 2022 9 | 31 | 31 | 62 |
| 2022 8 | 20 | 43 | 63 |
| 2022 7 | 26 | 31 | 57 |
| 2022 6 | 21 | 19 | 40 |
| 2022 5 | 36 | 49 | 85 |
| 2022 4 | 60 | 44 | 104 |
| 2022 3 | 59 | 63 | 122 |
| 2022 2 | 42 | 34 | 76 |
| 2021 1 | 59 | 44 | 103 |
| 2021 12 | 41 | 54 | 95 |
| 2021 11 | 41 | 54 | 95 |
| 2021 10 | 41 | 44 | 85 |
| 2021 9 | 32 | 33 | 65 |
| 2021 8 | 27 | 19 | 46 |
| 2021 7 | 44 | 22 | 66 |
| 2021 6 | 25 | 35 | 60 |
| 2021 5 | 26 | 33 | 59 |
| 2021 4 | 42 | 47 | 89 |
| 2021 3 | 68 | 36 | 104 |
| 2021 2 | 49 | 18 | 67 |
| 2020 1 | 39 | 21 | 60 |
| 2020 12 | 28 | 17 | 45 |
| 2020 11 | 24 | 10 | 34 |
| 2020 10 | 5 | 12 | 17 |
| 2020 9 | 32 | 9 | 41 |
| 2020 8 | 24 | 18 | 42 |
| 2020 7 | 22 | 14 | 36 |
| 2020 6 | 38 | 22 | 60 |
| 2020 5 | 28 | 12 | 40 |
| 2020 4 | 39 | 19 | 58 |
| 2020 3 | 29 | 20 | 49 |
| 2020 2 | 2 | 1 | 3 |
| 2020 1 | 4 | 2 | 6 |
| 2019 12 | 8 | 2 | 10 |
| 2019 11 | 2 | 0 | 2 |
| 2019 10 | 0 | 1 | 1 |
| 2019 9 | 10 | 1 | 11 |
| 2019 8 | 4 | 0 | 4 |
| 2019 7 | 4 | 4 | 8 |
| 2019 6 | 5 | 2 | 7 |
| 2019 5 | 4 | 9 | 13 |
| 2019 4 | 3 | 11 | 14 |
| 2019 3 | 2 | 4 | 6 |
| 2019 2 | 3 | 2 | 5 |
| 2019 1 | 3 | 1 | 4 |
| 2018 12 | 0 | 4 | 4 |
| 2018 11 | 4 | 0 | 4 |
| 2018 10 | 3 | 0 | 3 |
| 2018 9 | 2 | 0 | 2 |
| 2018 5 | 0 | 1 | 1 |
| 2018 3 | 2 | 2 | 4 |
| 2018 2 | 22 | 5 | 27 |
| 2018 1 | 27 | 4 | 31 |
| 2017 12 | 36 | 8 | 44 |
| 2017 11 | 18 | 6 | 24 |
| 2017 10 | 36 | 4 | 40 |
| 2017 9 | 27 | 6 | 33 |
| 2017 8 | 29 | 6 | 35 |
| 2017 7 | 34 | 5 | 39 |
| 2017 6 | 35 | 6 | 41 |
| 2017 5 | 24 | 5 | 29 |
| 2017 4 | 29 | 4 | 33 |
| 2017 3 | 22 | 31 | 53 |
| 2017 2 | 15 | 8 | 23 |
| 2016 1 | 22 | 8 | 30 |
| 2016 12 | 36 | 17 | 53 |
| 2016 11 | 47 | 10 | 57 |
| 2016 10 | 39 | 17 | 56 |
| 2016 9 | 43 | 11 | 54 |
| 2016 8 | 34 | 4 | 38 |
| 2016 7 | 21 | 5 | 26 |
| 2016 6 | 4 | 0 | 4 |
| 2016 5 | 13 | 7 | 20 |
| 2016 4 | 9 | 5 | 14 |
| 2016 3 | 10 | 0 | 10 |
| 2016 2 | 4 | 4 | 8 |
| 2015 1 | 16 | 1 | 17 |
| 2015 12 | 14 | 3 | 17 |
| 2015 11 | 13 | 0 | 13 |
| 2015 10 | 10 | 7 | 17 |
| 2015 9 | 7 | 1 | 8 |
| 2015 8 | 10 | 2 | 12 |
| 2015 7 | 61 | 4 | 65 |
| 2015 6 | 38 | 3 | 41 |
| 2015 5 | 41 | 9 | 50 |
| 2015 4 | 42 | 12 | 54 |
| 2015 3 | 25 | 4 | 29 |
| 2015 2 | 20 | 2 | 22 |
| 2015 1 | 23 | 1 | 24 |
| 2014 12 | 15 | 5 | 20 |
| 2014 11 | 11 | 5 | 16 |
| 2014 10 | 16 | 2 | 18 |
| 2014 9 | 18 | 3 | 21 |
| 2014 8 | 14 | 4 | 18 |
| 2014 7 | 13 | 5 | 18 |
| 2014 6 | 16 | 1 | 17 |
| 2014 5 | 21 | 7 | 28 |
| 2014 4 | 12 | 5 | 17 |
| 2014 3 | 11 | 2 | 13 |
| 2014 2 | 4 | 1 | 5 |
Mostrar todo
